Performance of aquatic weed - Waste Myriophyllum spicatum immobilized in alginate beads for the removal of Pb(II) von Milojković, Jelena V., Lopičić, Zorica R., Anastopoulos, Ioannis P., Petrović, Jelena T., Milićević, Sonja Z., Petrović, Marija S., Stojanović, Mirjana D.

Volltext

Mechanism of stearic acid adsorption to calcite von Mihajlović, Slavica R., Vučinić, Dušica R., Sekulić, Živko T., Milićević, Sonja Z., Kolonja, Božo M.

Volltext

Experience from Development of Once-Weekly Glucagon-Like Peptide-1 Receptor Agonist (GLP-1 RA) Dulaglutide for Treatment of Type 2 Diabetes Mellitus von Milicevic, Z

Volltext

Safety and efficacy of once-weekly dulaglutide versus sitagliptin after 2years in metformin-treated patients with type 2 diabetes (AWARD-5): a randomized, phase III study von Weinstock, R S, Guerci, B, Umpierrez, G, Nauck, M A, Skrivanek, Z, Milicevic, Z

Volltext

Activation of cortical and inhibited differentiation of medullary epithelial cells in the thymus of lymphotoxin‐beta receptor‐deficient mice: an ultrastructural study von Milićević, N. M., Nohroudi, K., Milićević, Ž., Westermann, J.

Volltext

Monotherapy with the once-weekly GLP-1 analogue dulaglutide for 12 weeks in patients with Type 2 diabetes: dose-dependent effects on glycaemic control in a randomized, double-blind... von Grunberger, G., Chang, A., Garcia Soria, G., Botros, F. T., Bsharat, R., Milicevic, Z.

Volltext

Dose-finding results in an adaptive, seamless, randomized trial of once-weekly dulaglutide combined with metformin in type 2 diabetes patients (AWARD-5) von Skrivanek, Z., Gaydos, B. L., Chien, J. Y., Geiger, M. J., Heathman, M. A., Berry, S., Anderson, J. H., Forst, T., Milicevic, Z., Berry, D.

Volltext

Low incidence of anti-drug antibodies in patients with type 2 diabetes treated with once-weekly glucagon-like peptide-1 receptor agonist dulaglutide von Milicevic, Z., Anglin, G., Harper, K., Konrad, R. J., Skrivanek, Z., Glaesner, W., Karanikas, C. A., Mace, K.

Volltext

Differential effects of once-weekly glucagon-like peptide-1 receptor agonist dulaglutide and metformin on pancreatic β-cell and insulin sensitivity during a standardized test meal... von Mari, A., Del Prato, S., Ludvik, B., Milicevic, Z., de la Peña, A., Shurzinske, L., Karanikas, C. A., Pechtner, V.

Volltext

Safety and efficacy of once-weekly dulaglutide versus sitagliptin after 2 years in metformin-treated patients with type 2 diabetes (AWARD-5): a randomized, phase III study von Weinstock, R. S., Guerci, B., Umpierrez, G., Nauck, M. A., Skrivanek, Z., Milicevic, Z.

Volltext

1.2 - Experience from Development of Once-Weekly Glucagon-Like Peptide-1 Receptor Agonist (GLP-1 RA) Dulaglutide for Treatment of Type 2 Diabetes Mellitus von Milicevic, Z.

Volltext

Molecular characterization of hsp90 isoforms in colorectal cancer cells and its association with tumour progression von MILICEVIC, Z, BOGOJEVIC, D, MIHAILOVIC, M, PETROVIC, M, KRIVOKAPIC, Z

Volltext

А critical role for molecular chaperones in Alzheimer's disease von Milicevic, Z, Spremo-Potparevic, B, Zivkovic, L, Bajic, V

Volltext

Status and perspectives of distance e-learning in higher education institutions von V Milićević, N Denić, Z Milićević, Lj Arsić, M Spasić-Stojković

Volltext

A study on the genotoxic effects of 8-Cl-cAMP on human lymphocytes in vitro von Bajić, V., Djelić, N., Spremo-Potparević, B., Živković, L., Milićević, Z.

Volltext

Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled p... von Frias, Juan Pablo, Nauck, Michael A, Van, Joanna, Kutner, Mark E, Cui, Xuewei, Benson, Charles, Urva, Shweta, Gimeno, Ruth E, Milicevic, Zvonko, Robins, Deborah, Haupt, Axel

Volltext

Involution of Bursa Cloacalis (Fabricii) and Thymus in Cyclosporin A-Treated Chickens von Milićević, Z, Zivanovi, V, Milićević, N M

Volltext

Advanced glycation endproducts in peripheral nerve in type 2 diabetes with neuropathy von Misur, I, Zarković, K, Barada, A, Batelja, L, Milicević, Z, Turk, Z

Volltext

Reduction of triglyceride-rich lipoproteins with retatrutide in type 2 diabetes may be explained by concurrent reduction in ANGPTL3/8 levels von Wen, Y, Lemen, D, Chen, Y, Lin, Y, Thomas, M, Hartman, M, Coskun, T, Milicevic, Z, Haupt, A, Ruotolo, G, Konrad, R

Volltext

Triple-hormone receptor agonist retatrutide significantly improves lipoprotein and apolipoprotein profiles in participants with obesity or overweight von Nicholls, S, Pirro, V, Lin, Y, Wilson, J, Duffin, K, Zhen, E, Harris, C, Thomas, M, Hartman, M, Coskun, T, Milicevic, Z, Haupt, A, Ruotolo, G

Volltext